Triptans in migraine: a comparative review of pharmacology, pharmacokinetics and efficacy.
about
Recent advances in the diagnosis and management of migraineThe optimal management of headaches in children and adolescentsThe 5-HT1F receptor agonist lasmiditan as a potential treatment of migraine attacks: a review of two placebo-controlled phase II trialsThe pharmacological profile and clinical prospects of the oral 5-HT1F receptor agonist lasmiditan in the acute treatment of migraineProinflammatory mediators and migraine pathogenesis: moving towards CGRP as a target for a novel therapeutic classProtective Roles of N-acetyl Cysteine and/or Taurine against Sumatriptan-Induced HepatotoxicityDistribution of 5-HT1B and 5-HT1D receptors in the inner ear.Triptans and serious adverse vascular events: data mining of the FDA Adverse Event Reporting System database.How does almotriptan compare with other triptans? A review of data from placebo-controlled clinical trials.Use and misuse of triptans in France: data from the GRIM2000 population survey.Intranasal Pharmacokinetic Data for Triptans Such as Sumatriptan and Zolmitriptan Can Render Area Under the Curve (AUC) Predictions for the Oral Route: Strategy Development and Application.Efficacy, speed of action and tolerability of almotriptan in the acute treatment of migraine: pooled individual patient data from four randomized, double-blind, placebo-controlled clinical trials.Frovatriptan is Effective and Well Tolerated in Korean Migraineurs: A Double-Blind, Randomized, Placebo-Controlled TrialEfficacy and pharmacokinetic activity of frovatriptan compared to rizatriptan in patients with moderate-to-severe migraine.Triptans (serotonin, 5-HT1B/1D agonists) in migraine: detailed results and methods of a meta-analysis of 53 trials.One hundred years of migraine research: major clinical and scientific observations from 1910 to 2010.Eletriptan for the treatment of migraine in patients with previous poor response or tolerance to oral sumatriptan.Efficacy of dosing and re-dosing of two oral fixed combinations of indomethacin, prochlorperazine and caffeine compared with oral sumatriptan in the acute treatment of multiple migraine attacks: a double-blind, double-dummy, randomised, parallel groNew paradigms in the recognition and acute treatment of migraine.Why pharmacokinetic differences among oral triptans have little clinical importance: a comment.A double-blind, randomized, multicenter, Italian study of frovatriptan versus rizatriptan for the acute treatment of migraine.Finding new drug targets for the treatment of migraine attacks.A double-blind, randomized, multicenter, Italian study of frovatriptan versus almotriptan for the acute treatment of migraineNeurologic bases for comorbidity of balance disorders, anxiety disorders and migraine: neurotherapeutic implicationsEffects of the CGRP receptor antagonist BIBN4096BS on capsaicin-induced carotid haemodynamic changes in anaesthetised pigsTriptans attenuate capsaicin-induced CREB phosphorylation within the trigeminal nucleus caudalis: a mechanism to prevent central sensitization?Possible role of alpha-adrenoceptor subtypes in acute migraine therapy.Subcutaneous delivery of sumatriptan in the treatment of migraine and primary headache.A review of rizatriptan, a quick and consistent 5-HT1B/1D agonist for the acute treatment of migraine.Triptans and chest symptoms: the role of pulmonary vasoconstriction.Triptans and CNS side-effects: pharmacokinetic and metabolic mechanisms.An in vitro interethnic comparison of monoamine oxidase activities between Japanese and Caucasian livers using rizatriptan, a serotonin receptor 1B/1D agonist, as a model drug.Pharmacoepidemiology I: a review of pharmacoepidemiologic study designs.Psilocybin dose-dependently causes delayed, transient headaches in healthy volunteers.Sumatriptan does not change calcitonin gene-related peptide in the cephalic and extracephalic circulation in healthy volunteersWhat can be learned from the history of recurrence in migraine? A commentDoes sumatriptan cross the blood-brain barrier in animals and man?Verisimilitude (or "truthlikeness") as an alternative to pro and cons: migraine and cluster headache mechanisms.Motion sickness in migraine sufferers.Infrequent or non-response to oral sumatriptan does not predict response to other triptans--review of four trials.
P2860
Q24535949-9EE41F0E-8EC0-469F-ADD1-0C5332C5F52CQ26770813-39B99FEB-8826-4939-B0C7-874BF4F89E1BQ26829564-B33AC2C7-4FFB-4ED7-ACBC-D316558F43D9Q27008834-DDBB74F1-6076-4DE6-BAB0-248EC4D8B7E4Q28292548-02AA5448-0B58-4C17-B04F-D06E10717D88Q28468548-E921D69E-ED3B-4104-BB12-19CBBE819C97Q30474698-94A09EB5-C3B9-4761-9979-884A5E688051Q30660036-0432F43C-7214-419F-8140-1283A4DC4AF8Q30692301-9B8A0B56-725F-45D5-9475-15C47B6A0DCAQ30910777-08453007-8824-4D0E-A24A-71C9B939F28BQ31044224-18DD46AA-3A43-4CB8-85ED-C4709F0C077AQ33237366-35BF3DF3-DA8C-4860-8E0C-81FB1BA87005Q33775913-5BF542C6-F896-48BD-905E-1FD34CE10E74Q33958060-F3315E99-4C21-484F-9A2D-DA547A58F60DQ34154647-E734C8DB-23AD-49EE-B3B4-9F0B39A5FD33Q34180539-FBDC97A6-47B0-4957-96F6-5310EC6D73B5Q34205990-0B8BFC55-CE5F-4F86-866E-B36C8C1F8236Q34581061-857ECBF4-AD2D-4BC2-8EB2-36C5B306D98CQ34634345-CEE78C8B-74D4-42D6-8B0D-D6F843010C4EQ34770884-8A3D803B-1555-4093-832B-CD9E53A49EADQ34786088-DD6B535C-F32A-4A48-AEFB-E26628626D54Q34954050-EF8A6523-E3E2-4FA3-B3FB-A9A0411C90C3Q34981791-B42BCD52-2B6A-4883-AD99-66FB2E39FC08Q35023333-B1DAD454-0C6F-4692-9725-317F98EAA0E0Q35045720-F7643B0F-42C9-4D02-9288-D64E48BF68A9Q35113494-7FCBF5E6-D1C3-49AD-97AC-CC33E304CB10Q35115423-B76E8159-7449-4D78-82B7-B6A61C1E39AFQ35684215-1AC43561-F3D1-4D3B-8681-C7524C33148CQ35688196-12ECFE13-35DC-44B5-AD1E-16721AD328C1Q35696691-5C7BDC84-34B0-413A-BD08-ECA360070B2AQ35779019-334A9E30-9710-4BBC-A865-32ECFCEA958CQ35825843-594D7680-58EB-474B-887A-1752A7A0BB70Q35875447-4F7F8599-A9BF-4366-B530-0CF78C9045A6Q35936959-B19B86C9-63C9-43C6-BC29-CEBF549DC928Q36259595-4DC77BA0-769B-498A-BC13-69381F788856Q36260684-35C440D7-09F5-4798-BFAA-4E03E2D3AC8EQ36260908-D2F08D29-D9DB-44AE-82E1-A8D5385395DCQ36261133-6AA115DD-F8D0-406F-B20D-CA24A0DB0CBCQ36326249-CC313DAE-224E-4527-A77B-E09A0601A88EQ36373560-CF4AB8A0-D5F2-4464-84A6-194DF1CC7AA9
P2860
Triptans in migraine: a comparative review of pharmacology, pharmacokinetics and efficacy.
description
2000 nî lūn-bûn
@nan
2000 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
name
Triptans in migraine: a compar ...... pharmacokinetics and efficacy.
@ast
Triptans in migraine: a compar ...... pharmacokinetics and efficacy.
@en
Triptans in migraine: a compar ...... pharmacokinetics and efficacy.
@nl
type
label
Triptans in migraine: a compar ...... pharmacokinetics and efficacy.
@ast
Triptans in migraine: a compar ...... pharmacokinetics and efficacy.
@en
Triptans in migraine: a compar ...... pharmacokinetics and efficacy.
@nl
prefLabel
Triptans in migraine: a compar ...... pharmacokinetics and efficacy.
@ast
Triptans in migraine: a compar ...... pharmacokinetics and efficacy.
@en
Triptans in migraine: a compar ...... pharmacokinetics and efficacy.
@nl
P1433
P1476
Triptans in migraine: a compar ...... pharmacokinetics and efficacy.
@en
P2093
P2860
P304
P356
10.2165/00003495-200060060-00003
P577
2000-12-01T00:00:00Z
P6179
1020090057